BEFORE-MS

  • Research type

    Research Study

  • Full title

    Biomarker Evaluation for Future Outcome in Relapsing Multiple sclerosis - BEFORE-MS.

  • IRAS ID

    224527

  • Contact name

    Sarah Martin

  • Contact email

    sarah.martin33@nhs.net

  • Sponsor organisation

    NHS Greater Glasgow and Clyde

  • Duration of Study in the UK

    1 years, 8 months, 1 days

  • Research summary

    BEFORE-MS aims to gather prospective, contemporaneous samples of cerebrospinal fluid, blood and urine from patients undergoing routine outpatient diagnostic lumbar puncture and blood tests for investigation of possible demyelinating disease.

    It is expected that the majority of patients will go on to be given a diagnosis of multiple sclerosis (MS). Only after diagnosis of MS will patients be invited by their clinical team to participate in an observational study - Future MS. This is a distinct, national project and will require separate consent for participation at the Future MS first study visit.

    The research samples for BEFORE-MS will be taken in parallel with the routine clinical samples, and will not therefore require a separate additional procedure. The samples will be stored in a biobank and later linked to clinical outcome and specifically with Future MS, but also additional clinical information derived from NHS GGC clinical portal. Samples will be analysed for potential disease biomarkers.

  • REC name

    London - West London & GTAC Research Ethics Committee

  • REC reference

    17/LO/1611

  • Date of REC Opinion

    2 Oct 2017

  • REC opinion

    Further Information Favourable Opinion